Meerman J H, Ringer D P, Coughtrie M W, Bamforth K J, Gilissen R A
LACDR-Center for Bio-Pharmaceutical Sciences, Division of Toxicology, Leiden University, The Netherlands.
Chem Biol Interact. 1994 Jun;92(1-3):321-8. doi: 10.1016/0009-2797(94)90073-6.
Sulfation of the carcinogen N-hydroxy-2-acetylaminofluorene (N-OH-AAF) and structurally related hydroxamic acids by rat and human sulfotransferases was studied. There was a clear sex and age difference in the sulfation of N-OH-AAF and the other hydroxamic acids by rat liver cytosols; adult male rats had the highest sulfation activity. Experiments with purified aryl sulfotransferase IV (AST IV) indicated that the high expression of this enzyme in male rat liver may be responsible for these differences. No such sex or age difference was found for the sulfation of aromatic hydroxylamines. In cytosols of adult human livers, sulfation activity towards aromatic hydroxamic acids and hydroxylamines was clearly present, but activities were much lower than in rat liver cytosols. Sulfation activity towards these compounds was also found in fetal and neonatal liver and adrenals. These compounds probably are sulfated by several different sulfotransferases in humans.
研究了大鼠和人类磺基转移酶对致癌物N-羟基-2-乙酰氨基芴(N-OH-AAF)及结构相关异羟肟酸的硫酸化作用。大鼠肝脏胞质溶胶对N-OH-AAF和其他异羟肟酸的硫酸化作用存在明显的性别和年龄差异;成年雄性大鼠的硫酸化活性最高。对纯化的芳基磺基转移酶IV(AST IV)进行的实验表明,该酶在雄性大鼠肝脏中的高表达可能是造成这些差异的原因。对于芳香族羟胺的硫酸化作用,未发现此类性别或年龄差异。在成年人类肝脏的胞质溶胶中,对芳香族异羟肟酸和羟胺的硫酸化活性明显存在,但活性远低于大鼠肝脏胞质溶胶中的活性。在胎儿和新生儿的肝脏及肾上腺中也发现了对这些化合物的硫酸化活性。在人类中,这些化合物可能由几种不同的磺基转移酶进行硫酸化。